Cellular Therapeutics Limited

General information

Name:

Cellular Therapeutics Ltd

Office Address:

48 Grafton Street M13 9XX Manchester

Number: 10931123

Incorporation date: 2017-08-24

End of financial year: 31 August

Category: Private Limited Company

Status: Active

Description

Data updated on:

10931123 is the reg. no. for Cellular Therapeutics Limited. The company was registered as a Private Limited Company on 24th August 2017. The company has been on the British market for the last 7 years. The firm may be contacted at 48 Grafton Street in Manchester. The post code assigned to this address is M13 9XX. six years from now this business changed its registered name from Immetacyte to Cellular Therapeutics Limited. The company's declared SIC number is 72110 and their NACE code stands for Research and experimental development on biotechnology. 31st August 2022 is the last time when company accounts were filed.

As for this particular limited company, the majority of director's responsibilities up till now have been met by Robert H. and Neill M.. Amongst these two executives, Neill M. has administered limited company for the longest time, having been a vital addition to the Management Board since 2017.

  • Previous company's names
  • Cellular Therapeutics Limited 2018-03-29
  • Immetacyte Limited 2017-08-24

Financial data based on annual reports

Company staff

Robert H.

Role: Director

Appointed: 19 November 2019

Latest update: 2 March 2024

Neill M.

Role: Director

Appointed: 24 August 2017

Latest update: 2 March 2024

People with significant control

Immetacyte Limited
Address: 48 Grafton Street, Manchester, M13 9XX, United Kingdom
Legal authority England And Wales
Legal form Private Limited Company
Country registered United Kingdom
Place registered Companies House
Registration number 06709883
Notified on 26 February 2018
Ceased on 19 November 2019
Nature of control:
over 3/4 of shares
3/4 to full of voting rights
right to manage directors
Neill M.
Notified on 24 August 2017
Ceased on 26 February 2018
Nature of control:
over 3/4 of shares
3/4 to full of voting rights
right to manage directors

Accounts Documents

Account next due date 31 May 2024
Account last made up date 31 August 2022
Confirmation statement next due date 06 September 2024
Confirmation statement last made up date 23 August 2023
Annual Accounts
Start Date For Period Covered By Report 2017-08-24
End Date For Period Covered By Report 2018-08-31
Annual Accounts
Start Date For Period Covered By Report 2018-09-01
End Date For Period Covered By Report 2019-08-31
Annual Accounts
Start Date For Period Covered By Report 2019-09-01
End Date For Period Covered By Report 2020-08-31
Annual Accounts
Start Date For Period Covered By Report 2020-09-01
End Date For Period Covered By Report 2021-08-31
Annual Accounts
Start Date For Period Covered By Report 2021-09-01
End Date For Period Covered By Report 2022-08-31

Company filings

Filing category

Hide filing type
Accounts Capital Change of name Confirmation statement Incorporation Officers Persons with significant control Resolution
Free Download
Confirmation statement with no updates 23rd August 2023 (CS01)
filed on: 8th, September 2023
confirmation statement
Free Download Download filing (3 pages)

Search other companies

Services (by SIC Code)

  • 72110 : Research and experimental development on biotechnology
6
Company Age

Similar companies nearby

Closest companies